Evidence map›Paper›PMID 28859129›Full record

ArticlePloS one2017

Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.

Nadine Upton, David J Jackson, Alexandra A Nikonova, Suzie Hingley-Wilson, Musa Khaitov, Ajerico Del Rosario, Stephanie Traub, Maria-Belen Trujillo-Torralbo, Max Habibi, Sarah L Elkin and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01159782 (Human Model of Rhinovirus Induced Acute Asthma Exacerbations), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01159782 nacompletednot on this map

Human Model of Rhinovirus Induced Acute Asthma Exacerbations

TypeinterventionalSponsorImperial College LondonRan2011 to 2014Enrolled46ConditionsRhinovirus Infection in AsthmaArmsRhinovirus infection
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Nadine UptonAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-7030-6174
David J JacksonAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Alexandra A NikonovaNRC institute of Immunology FMBA, Moscow, Russian Federation.
Suzie Hingley-WilsonRespiratory Infection Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Musa KhaitovNRC institute of Immunology FMBA, Moscow, Russian Federation.
Ajerico Del RosarioAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Stephanie TraubAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Maria-Belen Trujillo-TorralboAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Max HabibiAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Sarah L ElkinImperial College Healthcare NHS Trust, London, United Kingdom.
Onn M KonImperial College Healthcare NHS Trust, London, United Kingdom.
Michael R EdwardsAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Patrick MalliaAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Joseph FootittAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Jonathan MacintyreAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Luminita A StanciuAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Sebastian L JohnstonAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Annemarie SykesAirway Disease Infection Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Imperial College Healthcare NHS Trust · GBAsthma UK · GBInstitute of Immunology and Physiology · RUImperial College London · GBKing's College London · GB

Funding

European Research Council 233015Medical Research Council G0601236Medical Research Council G0700552Medical Research Council G1000758Medical Research Council G1100238Medical Research Council MR/N007328/1
6 · The paper itself

Abstract

Rhinovirus infection is associated with the majority of asthma exacerbations. The role of fractalkine in anti-viral (type 1) and pathogenic (type 2) responses to rhinovirus infection in allergic asthma is unknown. To determine whether (1) fractalkine is produced in airway cells and in peripheral blood leucocytes, (2) rhinovirus infection increases production of fractalkine and (3) levels of fractalkine differ in asthmatic compared to non-asthmatic subjects. Fractalkine protein and mRNA levels were measured in bronchoalveolar lavage (BAL) cells and peripheral blood mononuclear cells (PBMCs) from non-asthmatic controls (n = 15) and mild allergic asthmatic (n = 15) subjects. Protein levels of fractalkine were also measured in macrophages polarised ex vivo to give M1 (type 1) and M2 (type 2) macrophages and in BAL fluid obtained from mild (n = 11) and moderate (n = 14) allergic asthmatic and non-asthmatic control (n = 10) subjects pre and post in vivo rhinovirus infection. BAL cells produced significantly greater levels of fractalkine than PBMCs. Rhinovirus infection increased production of fractalkine by BAL cells from non-asthmatic controls (P<0.01) and in M1-polarised macrophages (P<0.05), but not in BAL cells from mild asthmatics or in M2 polarised macrophages. Rhinovirus induced fractalkine in PBMCs from asthmatic (P<0.001) and healthy control subjects (P<0.05). Trends towards induction of fractalkine in moderate asthmatic subjects during in vivo rhinovirus infection failed to reach statistical significance. Fractalkine may be involved in both immunopathological and anti-viral immune responses to rhinovirus infection. Further investigation into how fractalkine is regulated across different cell types and into the effect of stimulation including rhinovirus infection is warranted to better understand the precise role of this unique dual adhesion factor and chemokine in immune cell recruitment.

Indexed as

Host-Pathogen InteractionsAdultAsthmaBronchoalveolar Lavage FluidCase-Control StudiesChemokine CX3CL1FemaleGene ExpressionHumansLeukocytes, MononuclearMacrophages, AlveolarMalePicornaviridae InfectionsRespiratory SystemRhinovirusRNA, MessengerChemokine CX3CL1CX3CL1 protein, humanRNA, Messenger

Identifiers

PMID28859129
PMCPMC5578648
OpenAlexW2751257044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.